Hsbc Holdings PLC Sells 81,108 Shares of GE HealthCare Technologies Inc. $GEHC

Hsbc Holdings PLC lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.0% in the 1st quarter, Holdings Channel.com reports. The firm owned 817,690 shares of the company’s stock after selling 81,108 shares during the quarter. Hsbc Holdings PLC’s holdings in GE HealthCare Technologies were worth $58,067,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of GEHC. Empowered Funds LLC boosted its position in GE HealthCare Technologies by 6.1% during the 1st quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after acquiring an additional 1,665 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in shares of GE HealthCare Technologies during the 1st quarter worth $259,000. Cresset Asset Management LLC boosted its position in GE HealthCare Technologies by 12.5% during the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock valued at $578,000 after purchasing an additional 865 shares in the last quarter. Jump Financial LLC boosted its position in GE HealthCare Technologies by 317.6% during the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after purchasing an additional 21,396 shares in the last quarter. Finally, Gamco Investors INC. ET AL grew its stake in GE HealthCare Technologies by 8.6% in the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after purchasing an additional 320 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have commented on GEHC. Mizuho decreased their price target on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Stifel Nicolaus set a $80.00 price objective on shares of GE HealthCare Technologies in a research report on Wednesday, April 29th. Piper Sandler decreased their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Royal Bank Of Canada started coverage on shares of GE HealthCare Technologies in a research note on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 target price for the company. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $85.00 price target on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $76.41.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Peter J. Arduini purchased 4,169 shares of the stock in a transaction on Thursday, April 30th. The stock was bought at an average price of $59.92 per share, with a total value of $249,806.48. Following the transaction, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. The trade was a 1.63% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kevin Lobo purchased 10,000 shares of the company’s stock in a transaction on Friday, May 22nd. The shares were purchased at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the purchase, the director owned 14,363 shares in the company, valued at approximately $921,817.34. The trade was a 229.20% increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders acquired 21,847 shares of company stock valued at $1,361,355. Company insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GEHC stock opened at $63.07 on Monday. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The firm has a market capitalization of $28.69 billion, a price-to-earnings ratio of 15.09, a PEG ratio of 1.72 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The stock’s 50-day simple moving average is $63.64 and its 200-day simple moving average is $71.89.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.35%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.